SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atreca, Inc. - BCEL
Atreca, Inc. (BCEL)
Last atreca, inc. earnings: 3/11 04:30 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
NEW YORK, March 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Atreca, Inc. (“Atreca” or the “Company”) (NASDAQ: BCEL). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Atreca and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On or around June 19, 2019, Atreca conducted its initial public offering (“IPO”), issuing 7,350,000 shares of common stock priced at $17.00 per share. Then, on March 11, 2020, Atreca issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2019. Among other results, Atreca reported fourth quarter GAAP earnings per share of -$0.72, falling $0.03 short of consensus estimates. On this news, Atreca’s stock price fell sharply, damaging
Show less
Read more
Impact Snapshot
Event Time:
BCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCEL alerts
High impacting Atreca, Inc. news events
Weekly update
A roundup of the hottest topics
BCEL
News
- SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCXPR Newswire
- Immunome: An Oncology Powerhouse In The Making [Seeking Alpha]Seeking Alpha
- Nested Therapeutics Strengthens Board of Directors with Appointment of New Chair and Directors [Yahoo! Finance]Yahoo! Finance
BCEL
Earnings
- 11/14/23 - Miss
BCEL
Sec Filings
- 4/22/24 - Form DEFM14A
- 4/17/24 - Form 4
- 4/11/24 - Form PREM14A
- BCEL's page on the SEC website